Reuters logo
BRIEF-Atara Biotherapeutics reports Q3 loss per share $1.02
November 9, 2017 / 1:24 PM / a month ago

BRIEF-Atara Biotherapeutics reports Q3 loss per share $1.02

Nov 9 (Reuters) - Atara Biotherapeutics Inc

* Atara Biotherapeutics Inc announces third quarter 2017 financial results and recent highlights

* Q3 loss per share $1.02

* Q3 earnings per share view $-0.98 -- Thomson Reuters I/B/E/S

* Atara Biotherapeutics Inc - ‍cash, cash equivalents and short-term investments as of Sept 30, 2017 totaled $200.2 million

* Atara Biotherapeutics Inc - ‍cash, cash equivalents and short-term investments will be sufficient to fund planned operations into Q1 2019​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below